Pulse Biosciences, Inc. (PLSE)

NASDAQ: PLSE · IEX Real-Time Price · USD

15.96

-0.46 (-2.80%)

At close: Jul 19, 2024, 12:00 AM

16.22

+0.26 (1.62%)

Pre-market: Jul 22, 2024, 9:07 AM EDT

Pulse Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Net Income	-42.55	-42.21	-58.51	-63.66	-49.85	-46.97	Upgrade
Depreciation & Amortization	1.2	1.21	1.36	1.15	1.1	1.16	Upgrade
Share-Based Compensation	8.04	7.18	5.19	14.6	10.08	11.29	Upgrade
Other Operating Activities	-2.95	0.78	4.95	-6.18	3.32	0.34	Upgrade
Operating Cash Flow	-36.25	-33.04	-47.01	-54.1	-35.37	-34.19	Upgrade
Capital Expenditures	-0.09	-0.12	-0.4	-0.44	-0.44	-0.61	Upgrade
Change in Investments	0	0	0	8	10.49	-9.49	Upgrade
Investing Cash Flow	-0.09	-0.12	-0.4	7.56	10.04	-10.1	Upgrade
Share Issuance / Repurchase	16.21	16.39	15.38	62.51	30.89	0.7	Upgrade
Debt Issued / Paid	0.91	-0.01	64.56	0.41	0	0	Upgrade
Other Financing Activities	-	-	-	-0.23	-	-0.61	Upgrade
Financing Cash Flow	17.13	16.39	79.94	62.69	30.89	0.08	Upgrade
Net Cash Flow	-19.21	-16.77	32.53	16.15	5.56	-44.2	Upgrade
Free Cash Flow	-36.34	-33.16	-47.41	-54.53	-35.81	-34.79	Upgrade
Free Cash Flow Margin	-	-	-6773.43%	-3845.84%	-	-	Upgrade
Free Cash Flow Per Share	-0.66	-0.69	-1.40	-1.95	-1.54	-1.68	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).